The biotechnology industry has become one of the fastest-growing industrial sectors in the world, and will change the structure and power mechanism of the traditional pharmaceutical industry, and substantially increase the productivity of other related fields. Israel has the capacity to succeed in the field of the biotechnology industry, and investing in the biotechnology sector will enable Israel to capitalize on future growth opportunities. By implementing the seven recommendations provided in the report, Israel's biotechnology industry will be able to generate more than $5 billion in market capitalization of biotechnology companies and $3 billion in annual biotechnology production value in 2010 (about 2-3% of the global annual production value of the biotechnology industry); and at the same time, create an annual production value of about $15 billion in other related fields, and substantially increase the level of productivity in the related fields. By 2010, direct employment in biotechnology in Israel will reach 14,000 (compared to about 4,000 at the end of 2000).
The Israeli government has officially placed the biotechnology industry on the national industrial development agenda. According to the consulting recommendations and planning requirements, since the second half of 2001, Israel has been launched such as the biotechnology special fund program and other specific projects that must be implemented by 2004, through the international tender for the construction of two specialized biotechnology incubators, upgrading of the Israeli biotechnology industry's GLP / GMP facilities, to ensure that the scale of Israel's biotechnology industry by 2010 to be able to The scale of Israel's biotechnology industry will reach about 3% of the annual output value of the global biotechnology industry by 2010, so that Israel's biotechnology industry can truly develop into a new pillar industry with international competitiveness.
Israel's advantages in the field of "platform biotechnology" are mainly concentrated in "bioinformatics and drug development", combined with its advantages in the field of computer technology and physical technology, will greatly enhance its competitiveness in this field, but Israel's research in the field of "genome and post-genome" is relatively weak, and needs to be strengthened.
Since the end of 2000, despite the escalation of the Israeli-Palestinian conflict and the downturn of the global high-tech industry, the Israeli government has adopted most of the recommendations of Monitor's Strategic Consulting Report on Israel's Biotechnology Industry, and has adopted a series of programs and measures to accelerate the development of Israel's biotechnology industry since the second half of 2001.
(1) On May 25, 2001, Prime Minister Sharon officially announced the establishment of the National Center for Biotechnology in Israel, which is based on Ben-Gurion University, with an estimated investment of 31 million US dollars. The establishment of this institution will not only stimulate the future development of Israel's biotechnology industry, but also combine the development of Israel's biological high-tech industry with the development of Israel's southern desert to promote regional development.
(2) In early 2002, Israel's Ministry of Industry and Trade, Industrial R & D program in the establishment of a new "NORRAR" fund program, specifically to support the "field of biotechnology," applied research and development activities, and to promote the transfer of biotechnology results to industry.
(3) In March 2002, Israel's Ministry of Industry and Trade formally approved a special budget of 100 million U.S. dollars for "the establishment of two specialized biotechnology incubators of international standards, the upgrading of the infrastructure for the pharmaceutical industry's clinical trials and animal experiments, as well as the establishment of an international consortium **** with the promotion of biotechnology results of the commercialization of the 'Early Seed Fund' and other new measures to promote the development of the biotechnology industry in Israel. technology industry in Israel.
(4) On March 19-21, 2002, the first "International Exhibition on Biotechnology" was held in Tel Aviv, Israel.
(5) The Israeli-American Committee on Science and Technology (IACST) is conducting a feasibility study for the establishment of a multi-purpose GMP development facility in Israel.
(6) The official launch of the "Israel Biotechnology Industry Plan 2000-2010", marking the biotechnology industry in Israel officially included in the "national industrial development agenda".